Alphatec Holdings, Inc. (ATEC)

NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04

$9.45+1.29%

Close 2026-09-04 · 1-day change

Standing thesis

The standing, falsifiable read: what has to stay true, and what would break it.

Turnaround

Intact: The reason to own it still holds.

The bull case

Alphatec aims for $882M revenue and $134M adjusted EBITDA in 2026. Recent quarters showed earnings beats and raised revenue guidance. The company is improving cash flow with a new $20M free cash flow target. These steps support a recovery from losses.

The bear case

Revenue declined in early 2026 and the company remains unprofitable. Debt issuance and capital allocation changes add financial risk. If growth stalls or losses continue, the turnaround may fail.

What's priced in

The market expects about 20% revenue growth and prices the stock roughly 36% below our valuation model. Our view aligns with consensus revenue growth but acknowledges elevated risk from the ongoing turnaround.

What has to stay true

Achieve approximately $134M adjusted EBITDA in 2026Intact
Marginprimary>= $134 million · FY26 (guidance)
Breaks if: adjusted EBITDA falls significantly below $134 million in FY26
Generate at least $20M free cash flow in 2026Intact
Cash Flowsupporting>= $20 million · FY26 (guidance)
Breaks if: free cash flow falls below $20 million in FY26
Maintain stable management and execute turnaround planIntact
Management ExecutionsupportingNo major negative management changes or failures in execution · next 4 quarters (qualitative)
Significant management departures or failure to execute turnaround plan

Source: QuarterlyIQ research model· Written 2026-07-08· Health checked 2026-09-04· Version 1· Status: Intact· Reviewed when the evidence changes

This is not a price target or investment advice.

Current Outlook

Week of Sep 5, 2026

A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.

ATEC's long-term thesis remains intact despite recent earnings misses.

What kind of bet this is

ATEC represents a growth-oriented investment in the healthcare sector. The company is focused on achieving revenue and profitability targets, but it is currently loss-making and faces elevated risks.

What's priced into Alphatec Holdings, Inc. (ATEC)

The market appears to have priced in a low expectations gap, suggesting that ATEC is considered cheap compared to its peers. However, the valuation reflects a justified stance given the company's recent performance and sector backdrop.

What the fundamentals likely do

Management is on track to meet its revenue and adjusted EBITDA targets for 2026, indicating a positive trajectory. However, the company has a history of earnings misses, which adds a layer of risk to its performance.

What Alphatec Holdings, Inc. (ATEC) hinges on

The future performance of ATEC hinges on its ability to meet guidance and the overall health of the healthcare sector. Key factors include the performance of sector leaders and broader economic indicators like job reports.

What changed in the latest read

What changed

The most important moves since the prior daily snapshot.

Short-term · Daily

label change · confidence_label
small change
Confidence changed from 'medium' to 'high'.

Yes, our read has strengthened. The latest earnings beat supports this improved outlook. There are no current threats to the thesis.

as of 2026-09-04

See upcoming information that could change the risk

Review the evidence to watch, what would become a concern, and what would make it less concerning.

Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.